aluates Reports

$ 0.0

Automative

Global Drugs for HIV Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-8G8241

Global and China Drugs for HIV Market Insights Forecast to 2027

BUY CHAPTERS

Global Drugs for HIV Market Research Report 2025

Code: QYRE-Auto-8G8241

Report

July 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

ViiV Healthcare

Gilead Sciences Inc

Merck Sharp& Dohme Corp

Bristol Myers Squibb Company

Janssen Pharmaceuticals, Inc.

Theratechnologies

Genentech Inc

AbbVie

Viatris Pharmaceuticals Inc.

Drugs for HIV Market Size

The global market for Drugs for HIV was valued at US$ 34160 million in the year 2024 and is projected to reach a revised size of US$ 50740 million by 2031, growing at a CAGR of 5.9% during the forecast period.

Drugs for HIV Market

HIV/AIDS is one of the most serious chronic diseases and the high prevalence of the disease in almost all parts of the world has resulted in an unprecedented awareness regarding the disease.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Drugs for HIV, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for HIV.

The Drugs for HIV market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs for HIV market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drugs for HIV companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drugs for HIV Market Report

Report Metric	Details
Report Name	Drugs for HIV Market
Accounted market size in year	US$ 34160 million
Forecasted market size in 2031	US$ 50740 million
CAGR	5.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Integrase Inhibitors Combination HIV Medicines Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ViiV Healthcare, Gilead Sciences, Inc, Merck Sharp & Dohme Corp, Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Theratechnologies Inc., Viatris Pharmaceuticals Inc., Genentech, Inc., AbbVie Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs for HIV company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Drugs for HIV Market growing?

Ans: The Drugs for HIV Market witnessing a CAGR of 5.9% during the forecast period 2025-2031.

What is the Drugs for HIV Market size in 2031?

Ans: The Drugs for HIV Market size in 2031 will be US$ 50740 million.

Who are the main players in the Drugs for HIV Market report?

Ans: The main players in the Drugs for HIV Market are ViiV Healthcare, Gilead Sciences, Inc, Merck Sharp & Dohme Corp, Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Theratechnologies Inc., Viatris Pharmaceuticals Inc., Genentech, Inc., AbbVie Inc.

What are the Application segmentation covered in the Drugs for HIV Market report?

Ans: The Applications covered in the Drugs for HIV Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others

What are the Type segmentation covered in the Drugs for HIV Market report?

Ans: The Types covered in the Drugs for HIV Market report are Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Integrase Inhibitors, Combination HIV Medicines, Others

Recommended Reports

Infectious Disease Drugs

Drug Testing & Services

Chronic Disease Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drugs for HIV Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

1.2.3 Integrase Inhibitors

1.2.4 Combination HIV Medicines

1.2.5 Others

1.3 Market by Application

1.3.1 Global Drugs for HIV Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drugs for HIV Market Perspective (2020-2031)

2.2 Global Drugs for HIV Growth Trends by Region

2.2.1 Global Drugs for HIV Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Drugs for HIV Historic Market Size by Region (2020-2025)

2.2.3 Drugs for HIV Forecasted Market Size by Region (2026-2031)

2.3 Drugs for HIV Market Dynamics

2.3.1 Drugs for HIV Industry Trends

2.3.2 Drugs for HIV Market Drivers

2.3.3 Drugs for HIV Market Challenges

2.3.4 Drugs for HIV Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drugs for HIV Players by Revenue

3.1.1 Global Top Drugs for HIV Players by Revenue (2020-2025)

3.1.2 Global Drugs for HIV Revenue Market Share by Players (2020-2025)

3.2 Global Drugs for HIV Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Drugs for HIV Revenue

3.4 Global Drugs for HIV Market Concentration Ratio

3.4.1 Global Drugs for HIV Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drugs for HIV Revenue in 2024

3.5 Global Key Players of Drugs for HIV Head office and Area Served

3.6 Global Key Players of Drugs for HIV, Product and Application

3.7 Global Key Players of Drugs for HIV, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Drugs for HIV Breakdown Data by Type

4.1 Global Drugs for HIV Historic Market Size by Type (2020-2025)

4.2 Global Drugs for HIV Forecasted Market Size by Type (2026-2031)

5 Drugs for HIV Breakdown Data by Application

5.1 Global Drugs for HIV Historic Market Size by Application (2020-2025)

5.2 Global Drugs for HIV Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Drugs for HIV Market Size (2020-2031)

6.2 North America Drugs for HIV Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Drugs for HIV Market Size by Country (2020-2025)

6.4 North America Drugs for HIV Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drugs for HIV Market Size (2020-2031)

7.2 Europe Drugs for HIV Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Drugs for HIV Market Size by Country (2020-2025)

7.4 Europe Drugs for HIV Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drugs for HIV Market Size (2020-2031)

8.2 Asia-Pacific Drugs for HIV Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Drugs for HIV Market Size by Region (2020-2025)

8.4 Asia-Pacific Drugs for HIV Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drugs for HIV Market Size (2020-2031)

9.2 Latin America Drugs for HIV Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Drugs for HIV Market Size by Country (2020-2025)

9.4 Latin America Drugs for HIV Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drugs for HIV Market Size (2020-2031)

10.2 Middle East & Africa Drugs for HIV Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Drugs for HIV Market Size by Country (2020-2025)

10.4 Middle East & Africa Drugs for HIV Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 ViiV Healthcare

11.1.1 ViiV Healthcare Company Details

11.1.2 ViiV Healthcare Business Overview

11.1.3 ViiV Healthcare Drugs for HIV Introduction

11.1.4 ViiV Healthcare Revenue in Drugs for HIV Business (2020-2025)

11.1.5 ViiV Healthcare Recent Development

11.2 Gilead Sciences, Inc

11.2.1 Gilead Sciences, Inc Company Details

11.2.2 Gilead Sciences, Inc Business Overview

11.2.3 Gilead Sciences, Inc Drugs for HIV Introduction

11.2.4 Gilead Sciences, Inc Revenue in Drugs for HIV Business (2020-2025)

11.2.5 Gilead Sciences, Inc Recent Development

11.3 Merck Sharp & Dohme Corp

11.3.1 Merck Sharp & Dohme Corp Company Details

11.3.2 Merck Sharp & Dohme Corp Business Overview

11.3.3 Merck Sharp & Dohme Corp Drugs for HIV Introduction

11.3.4 Merck Sharp & Dohme Corp Revenue in Drugs for HIV Business (2020-2025)

11.3.5 Merck Sharp & Dohme Corp Recent Development

11.4 Bristol-Myers Squibb Company

11.4.1 Bristol-Myers Squibb Company Company Details

11.4.2 Bristol-Myers Squibb Company Business Overview

11.4.3 Bristol-Myers Squibb Company Drugs for HIV Introduction

11.4.4 Bristol-Myers Squibb Company Revenue in Drugs for HIV Business (2020-2025)

11.4.5 Bristol-Myers Squibb Company Recent Development

11.5 Janssen Pharmaceuticals, Inc.

11.5.1 Janssen Pharmaceuticals, Inc. Company Details

11.5.2 Janssen Pharmaceuticals, Inc. Business Overview

11.5.3 Janssen Pharmaceuticals, Inc. Drugs for HIV Introduction

11.5.4 Janssen Pharmaceuticals, Inc. Revenue in Drugs for HIV Business (2020-2025)

11.5.5 Janssen Pharmaceuticals, Inc. Recent Development

11.6 Theratechnologies Inc.

11.6.1 Theratechnologies Inc. Company Details

11.6.2 Theratechnologies Inc. Business Overview

11.6.3 Theratechnologies Inc. Drugs for HIV Introduction

11.6.4 Theratechnologies Inc. Revenue in Drugs for HIV Business (2020-2025)

11.6.5 Theratechnologies Inc. Recent Development

11.7 Viatris Pharmaceuticals Inc.

11.7.1 Viatris Pharmaceuticals Inc. Company Details

11.7.2 Viatris Pharmaceuticals Inc. Business Overview

11.7.3 Viatris Pharmaceuticals Inc. Drugs for HIV Introduction

11.7.4 Viatris Pharmaceuticals Inc. Revenue in Drugs for HIV Business (2020-2025)

11.7.5 Viatris Pharmaceuticals Inc. Recent Development

11.8 Genentech, Inc.

11.8.1 Genentech, Inc. Company Details

11.8.2 Genentech, Inc. Business Overview

11.8.3 Genentech, Inc. Drugs for HIV Introduction

11.8.4 Genentech, Inc. Revenue in Drugs for HIV Business (2020-2025)

11.8.5 Genentech, Inc. Recent Development

11.9 AbbVie Inc.

11.9.1 AbbVie Inc. Company Details

11.9.2 AbbVie Inc. Business Overview

11.9.3 AbbVie Inc. Drugs for HIV Introduction

11.9.4 AbbVie Inc. Revenue in Drugs for HIV Business (2020-2025)

11.9.5 AbbVie Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

ViiV Healthcare

Gilead Sciences Inc

Merck Sharp& Dohme Corp

Bristol Myers Squibb Company

Janssen Pharmaceuticals, Inc.

Theratechnologies

Genentech Inc

AbbVie

Viatris Pharmaceuticals Inc.

List of Tables

Table 1. Global Drugs for HIV Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Table 3. Key Players of Integrase Inhibitors

Table 4. Key Players of Combination HIV Medicines

Table 5. Key Players of Others

Table 6. Global Drugs for HIV Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Drugs for HIV Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Drugs for HIV Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Drugs for HIV Market Share by Region (2020-2025)

Table 10. Global Drugs for HIV Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Drugs for HIV Market Share by Region (2026-2031)

Table 12. Drugs for HIV Market Trends

Table 13. Drugs for HIV Market Drivers

Table 14. Drugs for HIV Market Challenges

Table 15. Drugs for HIV Market Restraints

Table 16. Global Drugs for HIV Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Drugs for HIV Market Share by Players (2020-2025)

Table 18. Global Top Drugs for HIV Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for HIV as of 2024)

Table 19. Ranking of Global Top Drugs for HIV Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Drugs for HIV Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Drugs for HIV, Headquarters and Area Served

Table 22. Global Key Players of Drugs for HIV, Product and Application

Table 23. Global Key Players of Drugs for HIV, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Drugs for HIV Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Drugs for HIV Revenue Market Share by Type (2020-2025)

Table 27. Global Drugs for HIV Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Drugs for HIV Revenue Market Share by Type (2026-2031)

Table 29. Global Drugs for HIV Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Drugs for HIV Revenue Market Share by Application (2020-2025)

Table 31. Global Drugs for HIV Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Drugs for HIV Revenue Market Share by Application (2026-2031)

Table 33. North America Drugs for HIV Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Drugs for HIV Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Drugs for HIV Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Drugs for HIV Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Drugs for HIV Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Drugs for HIV Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Drugs for HIV Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Drugs for HIV Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Drugs for HIV Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Drugs for HIV Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Drugs for HIV Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Drugs for HIV Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Drugs for HIV Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Drugs for HIV Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Drugs for HIV Market Size by Country (2026-2031) & (US$ Million)

Table 48. ViiV Healthcare Company Details

Table 49. ViiV Healthcare Business Overview

Table 50. ViiV Healthcare Drugs for HIV Product

Table 51. ViiV Healthcare Revenue in Drugs for HIV Business (2020-2025) & (US$ Million)

Table 52. ViiV Healthcare Recent Development

Table 53. Gilead Sciences, Inc Company Details

Table 54. Gilead Sciences, Inc Business Overview

Table 55. Gilead Sciences, Inc Drugs for HIV Product

Table 56. Gilead Sciences, Inc Revenue in Drugs for HIV Business (2020-2025) & (US$ Million)

Table 57. Gilead Sciences, Inc Recent Development

Table 58. Merck Sharp & Dohme Corp Company Details

Table 59. Merck Sharp & Dohme Corp Business Overview

Table 60. Merck Sharp & Dohme Corp Drugs for HIV Product

Table 61. Merck Sharp & Dohme Corp Revenue in Drugs for HIV Business (2020-2025) & (US$ Million)

Table 62. Merck Sharp & Dohme Corp Recent Development

Table 63. Bristol-Myers Squibb Company Company Details

Table 64. Bristol-Myers Squibb Company Business Overview

Table 65. Bristol-Myers Squibb Company Drugs for HIV Product

Table 66. Bristol-Myers Squibb Company Revenue in Drugs for HIV Business (2020-2025) & (US$ Million)

Table 67. Bristol-Myers Squibb Company Recent Development

Table 68. Janssen Pharmaceuticals, Inc. Company Details

Table 69. Janssen Pharmaceuticals, Inc. Business Overview

Table 70. Janssen Pharmaceuticals, Inc. Drugs for HIV Product

Table 71. Janssen Pharmaceuticals, Inc. Revenue in Drugs for HIV Business (2020-2025) & (US$ Million)

Table 72. Janssen Pharmaceuticals, Inc. Recent Development

Table 73. Theratechnologies Inc. Company Details

Table 74. Theratechnologies Inc. Business Overview

Table 75. Theratechnologies Inc. Drugs for HIV Product

Table 76. Theratechnologies Inc. Revenue in Drugs for HIV Business (2020-2025) & (US$ Million)

Table 77. Theratechnologies Inc. Recent Development

Table 78. Viatris Pharmaceuticals Inc. Company Details

Table 79. Viatris Pharmaceuticals Inc. Business Overview

Table 80. Viatris Pharmaceuticals Inc. Drugs for HIV Product

Table 81. Viatris Pharmaceuticals Inc. Revenue in Drugs for HIV Business (2020-2025) & (US$ Million)

Table 82. Viatris Pharmaceuticals Inc. Recent Development

Table 83. Genentech, Inc. Company Details

Table 84. Genentech, Inc. Business Overview

Table 85. Genentech, Inc. Drugs for HIV Product

Table 86. Genentech, Inc. Revenue in Drugs for HIV Business (2020-2025) & (US$ Million)

Table 87. Genentech, Inc. Recent Development

Table 88. AbbVie Inc. Company Details

Table 89. AbbVie Inc. Business Overview

Table 90. AbbVie Inc. Drugs for HIV Product

Table 91. AbbVie Inc. Revenue in Drugs for HIV Business (2020-2025) & (US$ Million)

Table 92. AbbVie Inc. Recent Development

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Drugs for HIV Picture

Figure 2. Global Drugs for HIV Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Drugs for HIV Market Share by Type: 2024 VS 2031

Figure 4. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features

Figure 5. Integrase Inhibitors Features

Figure 6. Combination HIV Medicines Features

Figure 7. Others Features

Figure 8. Global Drugs for HIV Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Drugs for HIV Market Share by Application: 2024 VS 2031

Figure 10. Hospital Pharmacies Case Studies

Figure 11. Retail Pharmacies Case Studies

Figure 12. Online Pharmacies Case Studies

Figure 13. Others Case Studies

Figure 14. Drugs for HIV Report Years Considered

Figure 15. Global Drugs for HIV Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Drugs for HIV Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Drugs for HIV Market Share by Region: 2024 VS 2031

Figure 18. Global Drugs for HIV Market Share by Players in 2024

Figure 19. Global Top Drugs for HIV Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for HIV as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Drugs for HIV Revenue in 2024

Figure 21. North America Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Drugs for HIV Market Share by Country (2020-2031)

Figure 23. United States Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Drugs for HIV Market Share by Country (2020-2031)

Figure 27. Germany Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Drugs for HIV Market Share by Region (2020-2031)

Figure 35. China Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Drugs for HIV Market Share by Country (2020-2031)

Figure 43. Mexico Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Drugs for HIV Market Share by Country (2020-2031)

Figure 47. Turkey Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Drugs for HIV Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. ViiV Healthcare Revenue Growth Rate in Drugs for HIV Business (2020-2025)

Figure 51. Gilead Sciences, Inc Revenue Growth Rate in Drugs for HIV Business (2020-2025)

Figure 52. Merck Sharp & Dohme Corp Revenue Growth Rate in Drugs for HIV Business (2020-2025)

Figure 53. Bristol-Myers Squibb Company Revenue Growth Rate in Drugs for HIV Business (2020-2025)

Figure 54. Janssen Pharmaceuticals, Inc. Revenue Growth Rate in Drugs for HIV Business (2020-2025)

Figure 55. Theratechnologies Inc. Revenue Growth Rate in Drugs for HIV Business (2020-2025)

Figure 56. Viatris Pharmaceuticals Inc. Revenue Growth Rate in Drugs for HIV Business (2020-2025)

Figure 57. Genentech, Inc. Revenue Growth Rate in Drugs for HIV Business (2020-2025)

Figure 58. AbbVie Inc. Revenue Growth Rate in Drugs for HIV Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Anti AIDs Drug Market Insights Forecast to 2030

Human Immunodeficiency Virus HIV Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti HIV Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acquired Immunodeficiency Syndrome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Communicable Diseases Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HIV and AIDS Clinical Trials Market Research Report 2025

Global HIV Prevention Drug Market Research Report 2024

HIV Self Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prophylactic HIV Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antiretroviral Agent Market Research Report 2024

Global Long acting Anti HIV Drug Market Research Report 2024

Global HIV Therapy Drug Market Research Report 2025

Global HIV Antiretroviral Drug Market Research Report 2025

Tuberculosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HIV Clinical Trials Market Research Report 2025

Treatment for Communicable Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antiretroviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HIV Therapy Market Research Report 2025

HIV Antiretroviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions